Share This Link

Reasoning: Choice A reason: Thorazine (chlorpromazine) is a first-generation typical antipsychotic that acts primarily by blocking dopamine D2 receptors in the mesolimbic and mesocortical pathways. While it has a defined dosage range, its administration is not routinely guided by therapeutic drug monitoring of serum blood levels. Clinical response and tolerability, rather than measured serum concentrations, typically drive dosage adjustments, making it distinct from drugs requiring individualized blood-level-based dosing protocols.

Clozapine is an atypical antipsychotic with a complex receptor-binding profile, including antagonism at dopamine D4, serotonin 5-HT2A, and muscarinic receptors. Although plasma levels of clozapine can be monitored in specific clinical scenarios such as non-response or toxicity, routine therapeutic drug monitoring is not the standard method used to individualize its dosage. The primary safety monitoring concern for clozapine is agranulocytosis, tracked via absolute neutrophil count (ANC), not serum drug levels as a primary dosing tool.

Alprazolam is a benzodiazepine that exerts its anxiolytic effect by potentiating the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor complex, enhancing chloride ion conductance. Its dosing is individualized based on clinical response, degree of anxiety, age, hepatic function, and tolerance, rather than routine measurement of serum drug levels. Therapeutic drug monitoring is not a standard practice for alprazolam in routine clinical management.

Telling a client with OCD that their anxiety is irrational is a non-therapeutic and clinically counterproductive intervention. Individuals with OCD typically have insight into the fact that their obsessions and compulsions are excessive, yet they remain unable to control them due to dysregulation in the cortico-striato-thalamo-cortical (CSTC) circuit. Labeling the anxiety as irrational dismisses the client's subjective distress, damages the therapeutic relationship, increases feelings of shame and stigma, and does not address the neurobiological underpinnings of the disorder. It violates the principles of therapeutic communication.

Instructing a client with OCD to avoid discussing ritualistic behaviors with friends constitutes social isolation of the client's experiences and is not a recognized therapeutic nursing intervention. Social support and open communication about one's symptoms can actually serve as a protective factor against the shame and secrecy commonly associated with OCD. Restricting discussion does not reduce obsessive-compulsive symptomatology and may worsen anxiety by denying the client an outlet for emotional expression. Therapeutic communication encourages openness, not suppression.

Informing the client that their intrusive thoughts cannot be controlled is an unhelpful and potentially harmful statement that may reinforce feelings of hopelessness and helplessness. While OCD is characterized by ego-dystonic intrusive thoughts that clients struggle to dismiss, effective treatments such as cognitive-behavioral therapy (CBT) with ERP and pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, fluvoxamine, or clomipramine have demonstrated significant efficacy. Telling clients that control is impossible undermines therapeutic optimism and contradicts evidence-based clinical outcomes.

Reasoning: Choice A reason: Body integrity identity disorder (BIID), also referred to as body integrity dysphoria, is a rare and distinct psychiatric condition characterized by an intense and persistent desire to have a specific limb amputated or to be otherwise disabled, due to a perceived discrepancy between one's internal body schema and actual physical form. This disorder involves distorted perception of one's own body and has no clinical relationship to the accumulation of objects or anxiety triggered by removal of possessions. It is therefore not applicable to the clinical scenario described.

Body dysmorphic disorder (BDD) is classified within the obsessive-compulsive and related disorders spectrum in the DSM-5. It is characterized by a preoccupation with 1 or more perceived defects or flaws in physical appearance that are not observable or appear slight to others, leading to repetitive behaviors such as mirror checking or skin picking. BDD does not involve compulsive accumulation of objects, and the anxiety described in the scenario is specifically linked to the removal of collected items rather than any concern about physical appearance.

Oniomania, commonly known as compulsive buying disorder or shopping addiction, is characterized by excessive, uncontrolled, and repetitive purchasing behavior driven by the urge to shop rather than by need, leading to significant financial and psychosocial consequences. While it may share some features with OCD-spectrum disorders, oniomania involves the acquisition of items through purchasing, not the accumulation and inability to discard items already in one's possession. The described scenario involves retaining existing possessions, not compulsive purchasing, making this diagnosis incorrect.

Sugar (sucrose and other dietary carbohydrates) does not interact pharmacologically with monoamine oxidase inhibitors. MAOIs exert their antidepressant effect by irreversibly inhibiting monoamine oxidase enzymes (MAO-A and MAO-B), thereby increasing the availability of monoamine neurotransmitters including serotonin, norepinephrine, and dopamine in the synaptic cleft. Dietary sugar has no role in monoamine metabolism and does not pose any clinically significant interaction risk with MAOIs. Educating a client to avoid sugar while on MAOIs would be clinically inaccurate and misleading.

Calcium is an essential dietary mineral involved in bone metabolism, muscle contraction, nerve impulse transmission, and blood coagulation. It does not undergo metabolic processing via monoamine oxidase enzymes and does not interact with MAOIs in any pharmacologically relevant manner. Calcium-rich foods such as dairy products are not contraindicated during MAOI therapy. Client education regarding calcium restriction in the context of MAOI use is not supported by evidence-based pharmacological guidelines or clinical practice standards.

Potassium is an essential electrolyte critical for maintaining cellular membrane potential, cardiac rhythm, and neuromuscular function. Like calcium, potassium does not interact with MAOIs and is not metabolized by monoamine oxidase enzymes. Foods high in potassium, such as bananas, oranges, and potatoes, are not contraindicated in clients receiving MAOI therapy. Instructing a client to avoid potassium-rich foods in the context of MAOI use reflects a fundamental misunderstanding of MAOI pharmacology.

Lecturing is a one-directional, didactic approach to communication that is particularly ineffective with clients diagnosed with antisocial personality disorder (ASPD). Individuals with ASPD characteristically exhibit pervasive disregard for rules and authority, lack of remorse, deceitfulness, and manipulative behavior. A lecturing approach tends to provoke power struggles, resentment, and non-compliance in this population, as it implies a hierarchical dynamic that clients with ASPD are likely to resist or exploit. Evidence-based nursing communication strategies for ASPD discourage moralistic or preachy approaches.

Negotiation as a teaching strategy with clients diagnosed with ASPD is counterproductive because it inadvertently reinforces manipulative interpersonal dynamics. ASPD is characterized by a pervasive pattern of exploitation of others and disregard for social norms. Engaging in negotiation with such clients may be interpreted as flexibility in boundaries, which can be exploited. Consistent, firm, and clearly communicated boundaries are central to managing therapeutic relationships with clients with ASPD, and negotiation undermines the necessary therapeutic structure.

A challenging approach, which involves directly confronting or questioning the client's statements or behaviors, is inappropriate for clients with ASPD. These individuals have low frustration tolerance and are prone to hostile or aggressive responses when they perceive a threat to their control or dominance. Challenging a client with ASPD may escalate agitation, provoke defensiveness, or stimulate manipulative countermeasures. Therapeutic communication guidelines for ASPD emphasize consistency, clear limit-setting, and avoiding emotional engagement in confrontational dynamics.

While the assessment for the potential use of physical restraints may be relevant in specific clinical contexts where a client with bipolar disorder poses an imminent risk of harm to self or others during a severe manic episode, it is not the overarching priority intervention. Restraint use is governed by strict legal, ethical, and clinical guidelines and is considered a last resort after de-escalation, environmental modifications, and pharmacological interventions have been attempted or evaluated. The primary nursing priority must first be the broad concept of ensuring safety, within which restraint assessment may fall as a subcomponent.

Administering medications as ordered, including mood stabilizers such as lithium carbonate or valproate and atypical antipsychotics such as quetiapine or olanzapine, is an essential component of managing bipolar disorder and reducing the duration and severity of mood episodes. However, medication administration is a dependent nursing function that presupposes physician orders and addresses a specific aspect of treatment. According to Maslow's hierarchy of needs and the nursing priority framework, safety supersedes all other interventions. Medication administration supports safety but is secondary to the priority of ensuring it.

Maintaining hydration is particularly important in bipolar disorder management, especially for clients receiving lithium carbonate therapy, as sodium and fluid balance directly affect lithium serum levels and risk of toxicity. Dehydration can increase lithium concentrations to toxic levels, causing symptoms ranging from tremor and polyuria to seizures and cardiac dysrhythmia. Despite this importance, hydration maintenance is a physiological supportive measure that is subordinate to the overarching priority of client safety, which encompasses protection from physical harm, self-harm, and harm to others.

Exposure therapy is a cognitive-behavioral intervention primarily indicated for anxiety-related disorders, including post-traumatic stress disorder (PTSD), specific phobias, social anxiety disorder, obsessive-compulsive disorder (OCD), and panic disorder. It involves systematic, graduated exposure to feared stimuli with response prevention to achieve habituation and extinction of conditioned fear responses. While there is some evidence for its utility in reducing craving responses in substance use disorders through cue exposure techniques, it is not the standard community-based recovery referral program for clients with alcohol use disorder in the outpatient setting.

Psychoanalysis is a long-term psychodynamic therapy rooted in Freudian theory that explores unconscious conflicts, early developmental experiences, and defense mechanisms as contributors to psychological dysfunction. While psychodynamic principles may inform some therapeutic approaches in mental health care, psychoanalysis is not a standard, evidence-based referral program for the community-based recovery of clients with alcohol use disorder. It is resource-intensive, time-consuming, and does not address the immediate behavioral, physiological, and social dimensions of addiction recovery.

Dialectical behavior therapy (DBT) is a structured psychotherapeutic modality developed by Marsha Linehan, originally designed for the treatment of borderline personality disorder (BPD). It integrates cognitive-behavioral techniques with mindfulness and distress tolerance strategies, addressing emotional dysregulation, interpersonal dysfunction, and self-destructive behaviors. While DBT has been adapted and studied in the context of substance use disorders due to overlapping features with BPD, it is not the primary or standard referral program for outpatient alcohol use disorder recovery. Its application in substance use is more specialized and not a routine community referral.

Trusting behaviors are not characteristic of schizotypal personality disorder. According to the DSM-5, schizotypal personality disorder is defined by a pervasive pattern of social and interpersonal deficits, including marked discomfort with and reduced capacity for close relationships, as well as cognitive and perceptual distortions and eccentric behaviors. Individuals with this disorder typically exhibit pervasive suspiciousness and paranoid ideation in social situations, making trust difficult to establish or maintain. Describing trusting behavior as a characteristic of this disorder is clinically inaccurate.

Dependency needs are a hallmark feature of dependent personality disorder (DPD), not schizotypal personality disorder. Clients with DPD exhibit excessive reliance on others for emotional support, difficulty making independent decisions, and fear of abandonment. In contrast, individuals with schizotypal personality disorder tend toward social isolation, interpersonal aloofness, and discomfort in close relationships, which is nearly the opposite of the dependent interpersonal style. Conflating these 2 disorders reflects a misclassification of personality disorder subtypes.

Perfectionism is a core feature of obsessive-compulsive personality disorder (OCPD), which is characterized by a pervasive preoccupation with orderliness, perfectionism, and mental and interpersonal control. OCPD is categorized under Cluster C personality disorders, whereas schizotypal personality disorder falls within Cluster A. The clinical features of schizotypal personality disorder center on odd beliefs, magical thinking, unusual perceptual experiences, social anxiety, and paranoia, not perfectionism or need for control. Attributing perfectionism to schizotypal personality disorder conflates 2 diagnostically distinct conditions.

The statement that people with panic attacks have fewer attacks when they also have agoraphobia is clinically incorrect and should not be included in a nursing education presentation on panic disorder. Agoraphobia, which is characterized by intense fear and avoidance of situations from which escape might be difficult or help unavailable during a panic attack, is a common comorbid condition that actually exacerbates the disability associated with panic disorder. DSM-5 recognizes panic disorder and agoraphobia as separate diagnoses that can co-occur, and the presence of agoraphobia typically worsens the clinical course and functional impairment, not reduces attack frequency.

The statement that persons with panic disorder rarely have a comorbid condition of depression is factually inaccurate and therefore inappropriate for inclusion in an educational presentation. Epidemiological and clinical research consistently demonstrates high comorbidity rates between panic disorder and major depressive disorder (MDD), with studies reporting that approximately 50 to 65% of individuals with panic disorder also meet diagnostic criteria for depression at some point in their lifetime. This comorbidity significantly complicates treatment and prognosis, and its acknowledgment is essential to comprehensive psychiatric nursing education. Including an incorrect statement would misinform nursing students.

As noted above, this choice is identical to choice a) and reflects a duplication error in the original question. Both state that people with panic attacks have fewer attacks when they also have agoraphobia. This statement is clinically false. The presence of agoraphobia in a client with panic disorder is associated with greater avoidance behavior, increased functional impairment, and a more chronic clinical course, not a reduction in panic attack frequency. This statement should not be included in any accurate nursing or medical education presentation on panic disorder.

Leaving a client who is actively experiencing a panic attack to report symptoms to the psychiatrist on duty is clinically inappropriate and potentially dangerous. A client in the midst of a panic attack experiences overwhelming terror, hyperventilation, palpitations, derealization, and an acute sense of impending doom. Abandonment during this acute state escalates anxiety, undermines the therapeutic relationship, and removes the calming presence of a healthcare provider. The nurse should remain with the client and communicate with other team members through alternate means while maintaining physical and emotional presence at the bedside.

Attempting to mimic the client's state of anxiety in an effort to demonstrate empathy is a fundamentally misguided and non-therapeutic nursing behavior. While empathy is a valued component of therapeutic communication, it involves understanding and reflecting the client's emotional experience, not replicating their physiological state of distress. Mimicking anxiety would likely escalate the client's sympathetic arousal through emotional contagion, increase environmental distress, and undermine the nurse's role as a stabilizing therapeutic presence. Nurses should model calm behavior to facilitate de-escalation of the panic response.

Informing a client during an acute panic attack that they are experiencing an acute exacerbation with positive prognosis and low morbidity may contain factual elements regarding the clinical course of panic disorder, but it is not the most appropriate immediate nursing intervention. During a panic attack, cognitive processing capacity is significantly impaired due to the acute stress response. Complex prognostic information delivered at this moment is unlikely to be absorbed and may appear dismissive of the client's immediate experience of terror. Reassurance about safety and the nurse's presence is a more immediately actionable and effective de-escalating strategy.